Transcription of 付表IC 指定を受けた医薬の有効成分（2回目の見直 …
{{id}} {{{paragraph}}}
Example: biology
付表IC 指定を受けた医薬の有効成分（2回目の見直 …
IC . (Sub-heading) Description (99m Tc) technetium (99m Tc) apcitide (123 ) iocanlidic acid (123 I). (123 ) ioflupane (123 I). (123 ) iometopane (123 I). (99m Tc) technetium (99m Tc) pintumomab (11 C) mespiperone (11 C). (153 Sm) samarium (153 Sm) lexidronam (99m Tc) technetium (99m Tc) nofetumomab merpentan seocalcitol paricalcitol ganaxolone pelubiprofen temiverine miproxifene lumefantrine pregabalin eldacimibe meluadrine levosalbutamol sinapultide opratonium iodide droxinavir agomelatine declopramide nateglinide nepafenac pexiganan lasinavir rivastigmine retigabine elinafide minalrestat xemilofiban targinine tresperimus moxilubant acreozast upenazime filaminast orazipone cariporide fudosteine fulvestrant furomine eplerenone almurtide fasidotril robalzotan cizolirtine aviptadil carafiban nepicastat abiraterone alinastine osanetant xaliproden clevidipine sabcomeline 1 4.
号(Sub-heading) 品名 Description 2933.39 サレズタント saredutant 2933.39 シブラフィバン sibrafiban 2933.39 シルペリソン silperisone
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: